Cost-efficiency analysis

A cost-efficiency analysis is needed when resource decisions are being made on the basis of overall averages or historical budgets, which hide where cost variation really lies. It applies when a hospital department wants to know how much each care process costs and why patients with the same diagnosis and a comparable case mix use very different resources. A historical budget tells you how much was spent in total, but not where cost variation concentrates or what share of it might be avoidable. A granular analysis of costs by process and by patient locates those opportunities with data, not intuition. It is the difference between knowing that a department shows cost variation or room for improvement and knowing exactly in which component, in which type of episode and by how much.

You need the sources that describe care activity and the resources it uses: clinical activity, cost accounting or internal billing, pharmacy, laboratory, inpatient stay, procedures and, where available, complexity or case-mix groupers. These sources are usually heterogeneous and held in different systems. The hospital provides these data; the service integrates them, harmonises the cost allocation criteria and validates the consistency between activity volumes and recorded costs before any analysis. The data do not need to arrive unified or cleaned: integrating sources and harmonising criteria are part of the work. What does shape the scope is the granularity available: the level of detail at which costs can be calculated depends on how far the data allow you to drill down to the episode and its components. If the data do not allow activity, episodes and cost components to be linked, the analysis may stay at a more aggregated level and not reach fine-grained costing by patient or episode.

Activity-based costing (ABC) is a costing method that assigns costs to care episodes based on the activities and resources they consume, with explicit allocation criteria, instead of spreading total expenditure across patients as an average. It applies when you want to understand cost variation among similar patients, which an average cost per process hides by construction. Allocating by averages assumes that all episodes with the same diagnosis cost the same; ABC costing lets you check how far that assumption holds, and locates the component and the patient subgroup where the difference concentrates. That granularity is what turns an aggregate spending figure into actionable information about where to act. Cost per episode is the foundation on which all subsequent efficiency analysis rests.

Units with room for improvement are identified by comparing their resource use with that of units achieving equivalent results, using efficient frontier analysis. This applies when you want to compare the technical efficiency of departments or centres without penalising those that treat more complex cases. An established technique for this is data envelopment analysis (DEA), which builds an efficiency frontier from the units that best combine resources and results, and measures how far the rest sit from that frontier. The result depends on how the inputs, outputs, units compared and adjustment variables are defined; that is why DEA is read as a prioritisation tool, not as an automatic ranking of culprits. Sitting far from the frontier shows where to look. It does not condemn a unit, because there may be contextual or case-mix factors that were not captured.

No savings figure in euros is promised in advance, and any promise of that kind should be treated with caution. The analysis quantifies the potential for improvement and the economic impact of the inefficiencies identified, but the size of the achievable savings depends on the granularity and quality of the hospital's own cost data and on the management decisions taken afterwards, not on the analytical methodology. What you do receive is the quantification of cost variation, the prioritisation of inefficiencies by their impact and the assessment of the economic impact of improvement initiatives once they are under way. The line is clear: quantifying and prioritising the potential, yes; promising a monetary figure before seeing the data, no. An honest analysis sizes the opportunity; it does not turn an estimated opportunity into a promise of fixed savings.

Quality is protected by cross-checking cost indicators against quality of care indicators, so that the savings opportunities identified do not compromise clinical outcomes. This applies to any efficiency analysis meant to guide care decisions, because a cost reduction that worsens outcomes is not an improvement; it simply moves the problem elsewhere. The operational distinction is precise: reducing stays is not the same as reducing inappropriate stays. The analysis focuses on variation and resource use that add no clinical value, not on across-the-board cuts. That is why opportunities are always cross-checked against outcome indicators before being flagged as improvements. The aim is to free up resources without touching what sustains the patient's outcome, not to save at any price.

Hospital cost and operational efficiency analysis is used to understand and optimise the cost of care processes within an organisation: how much each episode costs, where the variation lies and which units have room for improvement, using techniques such as ABC and DEA. Economic evaluation of health interventions (HEOR) fits when the question is whether an intervention, technology or treatment offers value compared with its alternative, using cost-effectiveness methods such as Markov models, QALYs and ICERs. They do not answer the same question: this service analyses the operational efficiency of what is already being done and identifies opportunities for improvement; HEOR compares the value of different interventions. They can complement each other, but operational cost-efficiency analysis looks inwards at the process, and HEOR looks towards the choice between options.

You receive reports with specific data: cost per episode, cost components, variation among comparable patients and a prioritisation of inefficiencies, ready to present to a senior management team or an efficiency committee. The service provides the quantitative evidence; the decision on resource allocation is made by the hospital. What you receive is not a set of recommendations for across-the-board cuts, but analyses that support a management decision, with the variation and the economic impact documented. This separation is intentional and protects the client: the people who decide on care resources are the centre's management, who know the context; the service gives them a documented quantitative basis on which to decide, not a decision already made that they then have to justify.